A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

NCT05428033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

574

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit/Hyperactivity Disorder

Interventions

DRUG: centanafadine capsule
OTHER: placebo capsule

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.